retatrutide nejm 2023 obesity trial ly3437943 Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people TRIUMPH-1 Trial Results: Retatrutide for

In combination with a GLP-1 some patients benefit from adding phentermine alongside Wegovy or Zepbound when additional appetite suppression is needed, particularly during the early dose-escalation phase of GLP-1 treatment

Reduced caloric and protein intake Hair follicles need amino acids (particularly keratin-building proteins) to thrive

Vitamin E is a fat-soluble antioxidant that is necessary for the maintenance of healthy-looking skin

Actively studied in Phase 2/3 trials and a major object of incretin literature

Ozempic has gained popularity for its potential to control binge eating episodes and reduce food intake

Copper peptides, especially GHK-Cu GHK-Cu is one of the best-known copper peptides